Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 136 AL 150

Regionally heterogeneous gamma alterations and their diagnostic value in early-onset Alzheimer's disease

Fide E, Yerlikaya D, Ada E, Yener G.

Int J Psychophysiol. 2026 Oct;228:113454. doi: 10.1016/j.ijpsycho.2026.113454. Epub 2026 Aug 20.

[Antibody therapy in Alzheimer's disease]

Schnieder M.

Z Gerontol Geriatr. 2026 Oct;59(6):522-530. doi: 10.1007/s00391-026-02640-8. Epub 2026 Sep 9.

Transcriptome-wide association analysis of Alzheimer's disease: construction and clinical validation of transcriptomic risk scores

Zhang PF, Juan Z, Han J, Wang Y, Zhu T, Pang D, Zheng X, Lu Z.

Eur Arch Psychiatry Clin Neurosci. 2026 Oct;276(7):3765-3775. doi: 10.1007/s00406-026-02338-3. Epub 2026 Aug 17.

EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker

Paranhos T, Katsumi Y, Brickhouse MJ, Eloyan A, Eckbo R, Zaitsev A, Du A, La Joie R, Thangarajah M, Taurone A, Vemuri P, Jack CR; as the LEADS Consortium; Hammers DB, Aisen PS, Beckett LA, Koeppe R, Kukull WA, Toga AW, Atri A, Clark DG, Day GS, Duara R, Graff-Radford NR, Grant IM, Honig LS, Johnson E, Jones DT, Masdeu JC, Mendez MF, Musiek ES, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha SJ, Turner RS, Wingo T, Wolk DA, Womack KB, Carrillo MC, Rabinovici GD, Apostolova LG, Dickerson BC, Eldaief MC, Touroutoglou A.

Neurology. 2026 Oct 13;107(7):e218519. doi: 10.1212/WNL.0000000000218519. Epub 2026 Aug 26.

Diagnostic value of blood p-tau subtypes in Alzheimer's disease progression and pathology: systematic review and meta-analysis

Zhang P, Huang D, Lu X, Zhong H, Liu C, Liu H, Duan X, Wu J.

Eur Arch Psychiatry Clin Neurosci. 2026 Oct;276(7):3329-3341. doi: 10.1007/s00406-026-02353-4. Epub 2026 Aug 22.

Plasma Biomarker Effects of Oral Valiltramiprosate/ALZ-801 in Early Alzheimer's Disease from Phase 3 and Phase 2 Trials: Analysis of Core Biomarkers and Correlations with Clinical and Neuroimaging Outcomes

Hey JA, Abushakra S, Power A, Watson D, Porsteinsson A, Sabbagh M, MacSweeney E, Cohen S, Boada M, Doraiswamy PM, Elahi FM, Rissman RA, Liang E, Flint S, Hristova E, Kesslak P, McLaine R, Albayrak A, Schaefer JF, Yu JY, Tolar L, Tolar M.

Drugs. 2026 Oct;86(10):1705-1721. doi: 10.1007/s40265-026-02381-3. Epub 2026 Sep 1.

Advances in Alzheimer's disease: mechanistic insights and therapeutic targets

Jia YJ, Ge YJ, Li B, Yang Y, Chen H, Liu J, Guo JH, Yu JT, Ye KQ, Wang JZ, Song W, Wang YJ.

Sci China Life Sci. 2026 Aug;69(8):2543-2574. doi: 10.1007/s11427-025-2991-7. Epub 2026 Jan 23.

Differential response to cognitive stimulation in moderate versus moderately severe Alzheimer's disease

Justo-Henriques SI, Silva RCG, Carvalho JO, Pérez-Sáez E, de São João RMV, Ribeiro O.

Can J Exp Psychol. 2026 Jun;80(2):143-157. doi: 10.1037/cep0000395. Epub 2026 Feb 5.

Rethinking Alzheimer's: novel miRNAs illuminate a disease beyond the brain

Novotný JS, Čarná M, Dammer EB, Mao Z, Stokin GB.

Mol Psychiatry. 2026 Jul;31(7):3595-3604. doi: 10.1038/s41380-026-03487-6. Epub 2026 Feb 13.

Endocytic scaffolds at the crossroads of Alzheimer's disease and neuronal aging

Shergill JK, Azarnia Tehran D.

Biol Chem. 2026 Feb 13;407(4-6):185-197. doi: 10.1515/hsz-2025-0250. Print 2026 Jul 24.

Role Shift of Glial Cells from Physiology to Pathology in Alzheimer's Disease: The Regulatory Impact of Exercise

Liu R, Deng Q, Gong L, Yang L.

Neurosci Bull. 2026 Jul;42(7):1617-1649. doi: 10.1007/s12264-026-01598-2. Epub 2026 Feb 16.

Protective mutations associated with APOE in Alzheimer's disease

Ma Y, Li Y, Wu G, Liu L, Tian M, Han X, Chen X, Xuan X, Zheng T, Gao X, Xia Q, Li F, Wang D.

Mol Psychiatry. 2026 Jul;31(7):3618-3636. doi: 10.1038/s41380-026-03496-5. Epub 2026 Feb 17.

Effectiveness of a Remote Physical Activity Intervention in Individuals with Alzheimer's Disease and their Caregivers: Results from a Randomized Trial

Ptomey LT, Helsel BC, Montgomery RN, Washburn RA, Sherman JR, Szabo-Reed AN, Vidoni ED, Gorczyca AM, Bodde A, Clina JG, Williams KN, Donnelly JE.

Med Sci Sports Exerc. 2026 Jul 1;58(7):1388-1398. doi: 10.1249/MSS.0000000000003974. Epub 2026 Mar 3.

Von Economo Neuron Loss in Frontotemporal Dementia: A Meta-Analysis of Neuropathological Studies

Talmasov D, Santillo AF, Hof PR.

Ann Clin Transl Neurol. 2026 Jun;13(6):1289-1293. doi: 10.1002/acn3.70362. Epub 2026 Mar 6.

Cross-talk between pyroptosis and miRNAs in Alzheimer disease neuropathology, therapeutic targeting of NLRP inflammasomes, and recent advances in nanoparticle-targeted therapy

Saad HM, Atef E, Aboushouk AA, Waheeb TS, Elsayed AE, Mohammed SAA.

J Neuropathol Exp Neurol. 2026 Jul 1;85(7):697-713. doi: 10.1093/jnen/nlag014.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias